A Comprehensive Review on Postmenopausal Osteoporosis in Women

被引:10
|
作者
Charde, Samruddhi H. [1 ]
Joshi, Abhishek [1 ]
Raut, Juhi [1 ]
机构
[1] Datta Meghe Inst Higher Educ & Res, Jawaharlal Nehru Med Coll, Community Med, Wardha, India
关键词
management; bone; lifestyle; postmenopause; osteoporosis; BONE-MINERAL DENSITY; VERTEBRAL FRACTURES; RISK-FACTORS; PRESERVATION; PREVENTION; WALKING; MANAGEMENT; DIAGNOSIS; EXERCISE;
D O I
10.7759/cureus.48582
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In India, a sizeable share of the female population is in the postmenopausal or perimenopausal stage. Issues related to aging in women are an increased risk of broken bones, a decrease in cortical and cancellous bone thickness, and a decrease in bone mineral density (BMD). Osteoporosis has a severely detrimental effect on the life of women, lowering their standard of living, decreasing the quality of their lives, and increasing their likelihood of fractures. It can be terrible if the fracture affects the hip or the spine since it could leave you immobile. Postmenopausal osteoporosis is related to lack of estrogen and lack of eggs produced by ovaries seen with increasing age. After many years of study, the role of estrogen is now well established in bone remodelling. Estrogen contributes to the resorption and strengthening of bone. It detects less density of bone at specific site and helps in strengthening the bone at that location. Treatment choices are based on severity, rate of advancement, and individual patient-specific characteristics. By adopting a lifecycle approach, all women should be educated about this illness and inspired to adopt a healthy lifestyle that includes regular exercise and a balanced diet. All premenopausal women should be advised to take vitamin D and calcium supplements regardless of whether or not they have any bone defects. Smoking and alcohol consumption should also be restricted. Pharmacological intervention is carried out on patients diagnosed with the disease. Drugs should be chosen based on their side effects and contradictions. It's crucial to do follow-up, and patient compliance should be closely observed. This article raises awareness of this widespread illness and helps women of postmenopausal age take the required precautions to stop bone thinning and manage its progress; moreover, it also reviews the literature already published on it.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Risk Assessment Tools for Osteoporosis Screening in Postmenopausal Women: A Systematic Review
    Carolyn J. Crandall
    Current Osteoporosis Reports, 2015, 13 : 287 - 301
  • [32] Effect of Osteoporosis Treatments on Osteoarthritis Progression in Postmenopausal Women: A Review of the Literature
    Ho, Wang-Chun
    Chang, Chung-Chih
    Wu, Wen-Tien
    Lee, Ru-Ping
    Yao, Ting-Kuo
    Peng, Cheng-Huan
    Yeh, Kuang-Ting
    CURRENT RHEUMATOLOGY REPORTS, 2024, 26 (05) : 188 - 195
  • [33] Risk Assessment Tools for Osteoporosis Screening in Postmenopausal Women: A Systematic Review
    Crandall, Carolyn J.
    CURRENT OSTEOPOROSIS REPORTS, 2015, 13 (05) : 287 - 301
  • [34] Postmenopausal Osteoporosis: A Clinical Review
    Watts, Nelson B.
    JOURNAL OF WOMENS HEALTH, 2018, 27 (09) : 1093 - 1096
  • [35] Romosozumab: A Review in Postmenopausal Osteoporosis
    Julia Paik
    Lesley J. Scott
    Drugs & Aging, 2020, 37 : 845 - 855
  • [36] Review of postmenopausal osteoporosis pharmacotherapy
    Mayes, Stacey L.
    NUTRITION IN CLINICAL PRACTICE, 2007, 22 (03) : 276 - 285
  • [37] Denosumab: A Review in Postmenopausal Osteoporosis
    Emma D. Deeks
    Drugs & Aging, 2018, 35 : 163 - 173
  • [38] Postmenopausal Osteoporosis: A Literature Review
    Bhatnagar, Aayushi
    Kekatpure, Aditya L.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
  • [39] Denosumab: A Review in Postmenopausal Osteoporosis
    Deeks, Emma D.
    DRUGS & AGING, 2018, 35 (02) : 163 - 173
  • [40] Preventing osteoporosis in symptomatic postmenopausal women
    Gallagher, J. Christopher
    Levine, Jeffrey P.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2011, 18 (01): : 109 - 118